We are headquartered in Hyderabad, the pharmaceutical capital of India. We have the expertise in manufacturing APIs since 1984 and PFIs since 1993. We have been marketing our products in the United States since 1987.
Granules has posted a sales of about Rs. 180 Crores in 2005-06. Our strategic goal is to offer a complete vertical integrated solution. Offering quality products has helped GIL grow, over the years, to become one of the largest manufacturers of Paracetamol in the world.
Granules India Ltd. (GIL) has a long history as a producer of active pharmaceutical ingredients (API's) and pharmaceutical formulation intermediates (PFIs) with complete vertical integration. We support customers with unique value, extensive product range and a global network of associates. Our expertise in manufacturing Pharmaceutical Formulation Intermediates (PFIs), which are Directly Compressible Granules, has helped customers to move to the next level of outsourcing in the pharmaceutical industry.
|